Literature DB >> 20170572

[Waiting times in breast disease clinics and psychological well-being: speedy care is better care].

Inge Henselmans1, Robbert Sanderman, Ans Smink, Adelita V Ranchor, Jakob de Vries.   

Abstract

OBJECTIVE: To examine the effect of diagnostic speed and the waiting time before surgery on the psychological well-being of patients in breast disease clinics.
DESIGN: Prospective cohort study
METHOD: Women with suspected breast cancer completed questionnaires about their psychological well-being before the first outpatient clinic visit (time T1: with malignancy (n = 149); without malignancy (n = 515)), shortly after diagnosis (T2: n = 96 and n = 432, respectively) and 2-3 months later (T3: with malignancy (n = 139)). Two months after the end of treatment (T4: with malignancy (n = 202)), women with breast cancer indicated which period they considered most stressful in retrospect. Diagnostic speed and the waiting time before surgery were categorized and the relation with well-being was examined. Analyses were controlled for age and cancer stage.
RESULTS: Although the period before diagnosis was experienced as stressful, diagnostic speed did not affect emotional well-being after a breast cancer diagnosis. However, a diagnosis that took a long time (> 2 weeks) did affect the emotional well-being of women who were not diagnosed with breast cancer. These women were worried and distressed for a longer period of time after diagnosis than women who received the favourable news sooner. The length of the waiting time before surgery did not affect the emotional well-being of patients thereafter: women who had surgery within two weeks were not worse or better off than women who had to wait longer. Yet, patients' emotional well-being did improve considerably after surgery, which indicates that short waiting times might shorten a period of psychological distress.
CONCLUSION: The results support a speedy diagnosis and surgery. There was no support for short waiting times having a negative psychological effect.

Entities:  

Mesh:

Year:  2010        PMID: 20170572

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  7 in total

1.  More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Authors:  Aisha S Sie; Wendy A G van Zelst-Stams; Liesbeth Spruijt; Arjen R Mensenkamp; Marjolijn J L Ligtenberg; Han G Brunner; Judith B Prins; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

2.  Same-day diagnosis based on histology for women suspected of breast cancer: high diagnostic accuracy and favorable impact on the patient.

Authors:  Maarten W Barentsz; Hester Wessels; Paul J van Diest; Ruud M Pijnappel; Carmen C van der Pol; Arjen J Witkamp; Maurice A A J van den Bosch; Helena M Verkooijen
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

3.  Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.

Authors:  Huan Song; Fang Fang; Unnur Valdimarsdóttir; Donghao Lu; Therese M-L Andersson; Christina Hultman; Weimin Ye; Lars Lundell; Jan Johansson; Magnus Nilsson; Mats Lindblad
Journal:  BMC Cancer       Date:  2017-01-03       Impact factor: 4.430

4.  Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.

Authors:  Joris P Bulte; Altuna Halilovic; Lambert J M Burgers; Coos J M Diepenbroek; Robin A K de la Roij; Ritse M Mann; Marloes van der Leest; Patricia H J van Cleef; Luc J A Strobbe; Johannes H W de Wilt; Peter Bult
Journal:  Am J Clin Pathol       Date:  2020-01-01       Impact factor: 2.493

5.  Improving cancer patient care: development of a generic cancer consumer quality index questionnaire for cancer patients.

Authors:  Judith C Booij; Marieke Zegers; Pauline M P J Evers; Michelle Hendriks; Diana M J Delnoij; Jany J D J M Rademakers
Journal:  BMC Cancer       Date:  2013-04-23       Impact factor: 4.430

6.  DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.

Authors:  Aisha S Sie; Liesbeth Spruijt; Wendy A G van Zelst-Stams; Arjen R Mensenkamp; Marjolijn J Ligtenberg; Han G Brunner; Judith B Prins; Nicoline Hoogerbrugge
Journal:  BMC Womens Health       Date:  2012-05-08       Impact factor: 2.809

7.  Lung Cancer Strategist Program: A novel care delivery model to improve timeliness of diagnosis and treatment in high-risk patients.

Authors:  William W Phillips; Jessica Copeland; Sophie C Hofferberth; Julee R Armitage; Sam Fox; Margaret Kruithoff; Claire de Forcrand; Paul J Catalano; Christopher S Lathan; Joel S Weissman; David D Odell; Yolonda L Colson
Journal:  Healthc (Amst)       Date:  2021-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.